For Immediate Release: February 2, 2017
Contact: Mr Benito Novas
info@stemcellsgroup.com
+1 305 560 5337
STEM CELL TRAINING TO HOST 1-WEEK COURSE FOR A DIPLOMAT IN CELL THERAPY AND TISSUE ENGINEERING
104-706 TechnoparkSsangyong, Korea – Stem Cell Training, a full-service stem cells research organization acting as a subsidiary to Stem Cells Group, an international Regenerative Medicinal institution committed to spreading access and information on stem cells research, this week announced they will be hosting a comprehensive, one-week course in Korea for anyone interested in achieving a Diploma in Cell Therapy and Tissue Engineering.
For those that complete the one-week course, they will receive certification by the Global Stem Cells Group, N-Biotek, and the President of the University of Westminster Graduate. Students will observe live hands-on surgeries and experiences with patients from the perspective of the participating faculty.
“The aim of this course is to prepare medical professionals with a high academic level in stem cell research within the laboratory and their translational focus at the practice level,” said Dr. Daeyong Kim Program Facilitator and Organizer. “Methods of Application of cell therapies in the different medical specialties will be taught and observed to all participating students.”
There will be four, highly experienced and accomplished teachers participating in the March program: Daeyong Kim, Ph.D., an internationally recognized medical educator and CEO of N-Biotek; Dr. Nang Lae Kim, MD, expert in degenerative disroders and the application of therapies with autologous stem cells; Sungkook Park, MD, specialist in regenerative medicine at N-Biotek and Head of laboratories; and Byungsoo Cho, MD, member of the University of Westminster where he works as a specialist in biotechnology.
“All students will walk away from the course knowing cell culture, including plating, trypanning, harvesting, and cryopreservation,” said Dr Daeyong Kim “This one-week course, to take place from March 11 to the 18, is not one prospective doctors and researchers are going to want to miss.”
For more information, or to sign up today, visit: http://stemcellsacademy.com

For Immediate Release: February 2, 2017
Mr Benito Novas
+1 305 560 5337
Contact: info@stemcellsgroup.com
STEM CELL TRAINING TO HOST NEW COURSE ON FEB 24TH AND 25TH IN BOGOTA, COLOMBIA
Bogota, Colombia – Stem Cell Training, a subsidiary of the global Stem Cells Group, an international organization committed to the study of regenerative medicine and how its development and integration can be used to revolutionize the success of our medicine today, this week announced they will be holding a comprehensive course on February 24 and 25 right in Bogota, Colombia.
Having been an Alma Mater in Regenerative Medicine and Cellular Therapies to close to 3,000 physicians worldwide, Stem Cell Training is intent on bringing their proven formula to eager students through courses and seminars that offer world-class research accompanied by the endorsement of medical schools and clinical enterprises.
“Students will gain access to highly visual and interactive learning resources, as well as medical expert one-on-one training and reintegration teaching on live patients using different protocols for isolating stem cells,” said Mr Benito Novas, Founder and Owner of Stem Cell Training. “All trainees will participate in different medical cases with supervision from expertly trained specialists.”
The two-day course will provide attendants with live demonstrations on the extraction, isolation, and application of PRP, Adipose, and Bone Marrow Stem Cells. Additionally, high-resolution step-by-step teaching videos will be provided to students for future reference and use.
Seats for each class are limited to 8 to 10 trainees, and are catered to fit everyone’s individual professional needs and requirements.
“Regenerative medicine is the medicine of our future,” said Dr Alfredo Hoyos “Our students will leave this course with the knowledge of anatomical locations, preparation of tumescent anesthesia, experience in SVF isolation, and so much more. Spread the word, and sign up for our two-day Bogota course today.”
For more information, or to learn about the program benefits, visit: https://cursocelulasmadre.com/entrenamiento-bogota-programa/.

For Immediate Release: January 27, 2017
Contact: Benito Novas
info@stemcellsgroup.com
+13055605337
STEM CELLS TRAINING TO HOLD TRAINING IN AXXIS HOSPITAL ON May 12TH AND 13TH
Miami, US – Stem Cells Training, a subsidiary of Global Stem Cells Group that specializes in biotechnology training and teaching the latest techniques in stem cell medicine to qualified physicians and high level healthcare professionals, this week announced they will be holding two days of training at Hospital AXXIS on May 12th and 13th for all interested attendees.
As their sixth training in Ecuador, Stem Cells Training is planning to host four more sessions in Quito throughout this year.
“We offer a unique, comprehensive approach to training physicians in our courses and seminars based on world-class stem cell research, derived from our Global Stem Cells Group affiliation,” said Benito Novas, Founder and Owner of Stem Cells Training. “We have an unprecedented passion for stem cell research and its potential for medical revolutions in our world, which is why we are trying our best to make it accessible in every country possible.”
Stem Cells Training has the endorsement of prestigious medical schools and verification of their clinical stem cells research. Their internationally sourced faculty emulates a diverse and talented group of researchers whom are renowned for their groundbreaking work in the area of stem cell research.
Above all, Stem Cells Training has worked to be the torchbearer for Regenerative Medicine and Cellular Therapies to close to 3,000 physicians worldwide.
“Though we’ve already reached thousands, holding seminars in hospitals globally will provide us with an even better avenue for spreading our knowledge and expertise,” said Benito Novas. “Spread the word on the availability of ours upcomings training dates, and visit our website for registering for comprehensive Stem Cells Training education and practical application.”
Officially called “Practical Stem Cell Training Course in a Clinical Environment,” time is running out to register.
For more information, visit: https://www.stemcelltraining.net

For Immediate Release: January 18, 2017
Contact: Mr Benito Novas. CEO and Founder Global Stem Cells Group
info@stemcellsgroup.com
+13055605337
STEM CELL CENTER INC. TO OPEN NEW, FULL-SERVICE INDIAN CENTER JANUARY 20, 2017
Punjab, India – Stem Cell Center Inc., a subsidiary of the Global Stem Cells Group, a group of international companies each dedicate to facilitating stem cell research and medicine, this week announced they will officially open the doors to their new Stem Cell Center in India this January 20th. The facility will be their 3rd Stem Cell Center in Asia, previously in Seoul and Manila, and now India. The official address is Cell Center SCO no. 13, Peer Muchalla, Zirakpur, Dist Mohali Punjab.
Borne from a passion for spreading the techniques and access to stem cell medicine and research across the world, the Stem Cell Center will focus on furthering the industry’s scientific and technological advancements to lead cutting edge stem cell development, treatments, and training.
“We are an organization of 30 members worldwide, making us the largest collective support and advisory network of Regenerative Medicine clinic and physician,” said Mr Benito Novas, Founder and Director at the Stem Cell Center. “Our center is poised to now offer regenerative medicine training to Indian physicians during the entire year.”
The Indian Stem Cell Center team was trained in their American facilities during September 2016, and completed their onsite Indian facility training at the beginning of this week.
Team members include: Dr. Satish K. Sood, MD, Dr. GyanPrakash, MBBS, PGDMCH, and Dr. Rama Sood, MD.
Adimarket, a subsidiary of the Global Stem Cells Group, provided a full Regenerative Medicine Lab for the Stem Cell Center in India.
“This center is ready to provide leading edge care and modern technology, all while incorporating the latest advancements in cellular therapies to patients worldwide,” said Dr. Rama Sood, MD, Owner of Stem Cells Center India. “Spread the word on the opening of our facility this Friday, and visit our website for getting in contact with our doctors.”
For those interested in being part of the Stem Cells Group network, visit: https://stemcellcenter.net or contact us at info@stemcellsgroup.com.

For Immediate Release: January 17, 2017
Contact:
Mr Benito Novas
Info@stemcellsgroup.com
+1305 560 5337
GLOBAL STEM CELLS GROUP TO PARTICIPATE IN THE MEXICAN ANTI AGING CONGRESS
Mexico City, Mexico – Global Stem Cells Group,htpp//www.stemcellsgroup.com/ a full-service collection of companies, each dedicated to facilitating stem cell research and medicine around the world, this week announced their founder and CEO, Mr. Benito Novas, will serve as a featured speaker in the main event of the 2017 Anti Aging Congress to be held in Mexico. http://www.medicina-antienvejecimiento.net/
Mr. Novas will cover the “State of Regenerative Medicine: A Guide to Stem Cell Research and Therapies” during his featured event. The lecture will provide insight into stem cell research and therapies introduction, as well as the rules that presently govern this unique group of therapies in the United States, Europe, Asia, and Latin America.
“The Anti Aging Congress is a prolific international event that facilitates invaluable idea, education, and information exchange between the leading players in the world’s stem cell research industry,” said Mr. Novas. “As someone who dedicates my life to the development and expansion of stem cell benefits in every aspect of medicine, I am honored to serve as one of the keynote speakers of the event.”
February 19, Global Stem Cells Group will organize an interactive workshop for a sustained discussion about important news regarding Regenerative Medicine and clinical trials currently being administered to increase patient health.
Additionally, the group will host a hands-on training for physicians attending the event. This training will provide attendees with 12 proprietary protocols that enable participants to test degenerative diseases right from their offices. Attendees will walk away with new skills they can apply to treating and developing solutions for patients with degenerative disablements.
There are only 10 vacancies left in the hands-on training course.
The 2017 Mexican Anti Aging Congress will officially take place February 17t to 19.
For more information, or to sign-up for the stem cell application course on February 19, visit: https://cursocelulasmadre.com/entrenamiento-cancun/.

Stem Cell Training and N-Biotek, Inc. have announced plans to launch a post-graduate studies program in stem cell and regenerative medicine, to be conducted in Seoul Korea in 2017.
MIAMI, JAN. 09, 2017—Stem Cell Training,Inc., a division of Global Stem Cells Group, Inc., and N-Biotek Inc have announced plans to launch a post graduate studies program in stem cell therapies and regenerative medicine in 2017.
The program will include Seven days of intensive, interactive training coursework with classroom instruction and laboratory practice through didactic lectures, hands-on practical experience in laboratory protocols and relevant lessons in regulatory practices. N-Biotek’s Chief Scientific Officer and Other leading Scientists will teach the coursework and perform laboratory instruction, accompanied by a series of guest lecturers from the Global Stem Cells Group faculty of scientists.
Attendees will receive hands-on training in techniques for a variety of laboratory processes, and gain insight into the inner workings of a cGMP laboratory and Korean FDA registered tissue bank. Regenerative medicine experts with more 15 years of experience in the field will train attendees and provide the necessary tools to implement regulatory and clinical guidelines in a cGMP laboratory setting
The graduate course is to be four times in Seoul in March 2017.
Course details, objectives and instruction include:
● Laboratory Training
● Hands-On Training
● Plating Stem Cells
● Harvesting and Freezing stem cells (perform counts and flow)
● Gram Stain
● Trypan
● Mycoplasma
● Gowning to enter cleanroom
● Flow Cytometry
● Endotoxin
● Sterility
● Environmental monitoring
● Calibration and PM
Didactic Lectures will include:
● Stem Cell Biology
● Cell Culture
● Trypsin
● Plating
● Flow Cytometry
● Gram Stain
● Trypan
● Potency (differentiation)
● Cryopreservation
● Quality control: endotoxin, sterility, mycoplasma
● Gowning to enter cleanroom
● Cleanroom Maintenance
● Environmental monitoring
Laboratory Protocols
For additional information, visit the Stem Cell Training, Inc. website, email info(at)stemcelltraining(dot)net, or call 305-560-5337
About Global Stem Cells Group:
Global Stem Cells Group, Inc. is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products and solutions. Founded in 2012, the company combines dedicated researchers, physician and patient educators and solution providers with the shared goal of meeting the growing worldwide need for leading edge stem cell treatments and solutions. With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries are uniquely positioned to become global leaders in cellular medicine.
Global Stem Cells Groups corporate mission is to make the promise of Regenerative medicine a reality for patients around the world. With each of GSCGs six operating companies focused on a separate research-based mission, the result is a global network of state-of-the-art stem cell treatments.
About Stem Cell Training, Inc.:
Stem Cell Training, Inc. is a multi-disciplinary company offering coursework and training in 35 cities worldwide. Coursework offered focuses on minimally invasive techniques for harvesting stem cells from adipose tissue, bone marrow and platelet-rich plasma. By equipping physicians with these techniques, the goal is to enable them to return to their practices, better able to apply these techniques in patient treatments.
The company’s training courses are designed to make the best use of stem cell technology available to treat various diseases in a manner that is accessible to everyone. Stem Cell Training, Inc.’s mission is to introduce the promising world of cellular medicine to everyone who can benefit from its application, and to provide high quality, effective and efficient training that complies with the highest medical standards to physicians worldwide.

After receiving a personal invitation from President Susumu Takayangi MD, Global Stem Cells Group and its Korean biotechnology partner, N-Biotek, participated in the 23rd Congress of the International Society of Aesthetic Plastic Surgeons that took place this October in Kyoto. With the assistance of more than 1500 physicians and surgeons from around the globe, the conference’s focus was to grow a global understanding of the importance of the aesthetic modalities in plastic and reconstructive surgery and the applications of cellular and regenerative medicine in this field.
The Congress brought together an expert panel for a series of lectures and discussions that hope to provide solutions and create new techniques in the coming years to be applied in plastic and reconstructive surgery. Influential scientific and clinical experts stood together and evaluated the state of research and clinical application.
The keynote speaker in the conference was the Nobel Laureate Shinja Yamanaka.  Dr Yamanaka won the award on 2012 for his creation of induced pluripotential stem cells. Yamanaka addressed among other things the importance of the regenerative medicine field opening a new frontier for the treatment of chronic degenerative conditions.
“We are excited to have attended the ISAPS conference once more. Our goal, as always, is to promote scientific training for physicians and research in stem cell technology that we hope will contribute to the global discussion on how these therapies can advance human health and longevity” says Benito Novas, founder and CEO.
Mr. Sanguk Ra, Business Director of N-Biotek, a biotechnology added ;”these are very exciting times, we see more and more physicians getting involved in regenerative medicine, and that of course puts more pressure on the scientists to help advance the field”
Both companies, as leaders of the industry, launched their new Turnkey Solution, a compact and cohesive laboratory as a concept for physicians’ offices, and the new Progenikine Kit, an enzyme based closed system for isolation of adipose derived stem cells.  To learn more, visit the Global Stem Cells Group website, www.stemcellsgroup.com.
About Global Stem Cells Group:
Global Stem Cells Group, Inc. is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products and solutions. Founded in 2012, the company combines dedicated researchers, physician and patient educators and solution providers with the shared goal of meeting the growing worldwide need for leading edge stem cell treatments and solutions. With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries are uniquely positioned to become global leaders in cellular medicine.  Global Stem Cells Group’s corporate mission is to make the promise of stem cell medicine a reality for patients around the world. With each of GSCG’s six operating companies focused on a separate research-based  mission, the result is a global network of state-of-the-art stem cell treatments.

On the 28th of September 2016, Global Stem Cells Group successfully hosted its 3rd annual International Stem Cells and Regenerative medicine symposium in Buenos Aires Argentina. This International Stem Cells and Regenerative medicine symposium was dignified by the participation of the most renowned and experienced physicians on stem cell and regenerative medicine from Latin America and Europe.
The symposium was also graced by an online participation of several physicians through online streaming and a speaker lineup which included highly coveted personalities from the areas of scientific research, clinical research and regulatory world. This team of prominent and talented specialists in medical research and international stem cell used the forum to share the recent discoveries and advancements in scientific research and medical science.
During the inauguration of the symposium, Global Stem Cells Group honored Dr. Joseph Purita for his lifetime achievements and contributions to the cellular and regenerative medicine and his guide to the Global Stem Cells Group faculty from its inception. Dr. Purita is a world renowned orthopedic surgeon and the pioneer in laser techniques in orthopedic surgery and the application of stem cells and PRP therapies for orthopedic injuries and diseases.
After the symposium, Stem Cell Training the group’s arm for physician education hosted a full enrollment workshop where several physicians from Latin America and Europe received hands on training on isolation and reintegration of adult stem cells, use of peptides and cellular secretions and orthomolecular interventions. The physicians were trained on global skills and capabilities required for the treatment of patients in the course of their medical practices and for career development.
To learn more about the 3rd Annual International Symposium on Stem Cells and Regenerative Medicine, visit the Global Stem Cells Group website, or email bnovas@stemcellsgroup.com, or call 305-560-5337.
About Global Stem Cells Group:
Global Stem Cells Group, Inc. is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products and solutions. Founded in 2012, the company combines dedicated researchers, physician and patient educators and solution providers with the shared goal of meeting the growing worldwide need for leading edge stem cell treatments and solutions. With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries are uniquely positioned to become global leaders in cellular medicine.